Karen D Wright Selected Research

Glioma (Gliomas)

1/2023	Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
11/2022	Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.
1/2022	Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.
1/2021	A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
12/2019	Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen D Wright Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 04/2012
7	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2009
7	Ependymoma 01/2021 - 10/2009
5	Glioma (Gliomas) 01/2023 - 12/2019
2	Diffuse Intrinsic Pontine Glioma 10/2018 - 06/2015
2	Medulloblastoma 09/2017 - 08/2012
2	Central Nervous System Neoplasms 04/2015 - 01/2015
1	Neuroblastoma 10/2022
1	Primitive Neuroectodermal Tumors (PNET) 10/2022
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2022
1	Sarcoma (Soft Tissue Sarcoma) 10/2022
1	Disease Progression 01/2021
1	Choroid Plexus Carcinoma 01/2018
1	Primary Ovarian Insufficiency 01/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2013
1	Necrosis 08/2012
1	Rhabdoid Tumor (Rhabdoid Tumors) 04/2012
1	Retinoblastoma (Glioblastoma, Retinal) 09/2010
1	Familial ependymoma 10/2009
1	Wilms Tumor (Wilm's Tumor) 09/2009

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2019
2	dipinacoline glutamateIBA 10/2018 - 06/2015
2	Methotrexate (Mexate)FDA LinkGeneric 04/2015 - 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	TabletsIBA 01/2021
1	Everolimus FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	MTOR InhibitorsIBA 01/2019
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018
1	HhAntag691IBA 09/2017
1	NucleotidesIBA 07/2017
1	vasectrin IIIIBA 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 12/2015
1	Alkylating AgentsIBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2012
1	Vincristine (Oncovin)FDA LinkGeneric 08/2012
1	Cisplatin (Platino)FDA LinkGeneric 08/2012
1	Therapeutic UsesIBA 08/2012

Therapy/Procedure

16	Therapeutics 01/2023 - 01/2009
6	Drug Therapy (Chemotherapy) 10/2022 - 09/2009
5	Radiotherapy 12/2019 - 09/2009
3	Craniospinal Irradiation 01/2015 - 04/2012
2	Precision Medicine 01/2022 - 07/2017
1	Molecular Targeted Therapy 11/2022
1	Adjuvant Chemotherapy 01/2015
1	Conformal Radiotherapy 08/2012